Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04829175 · ClinicalTrials.gov registry record
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
A clinical trial of Pelvic Organ Prolapse and Stress Urinary Incontinence, sponsored by Ethicon.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 10
- Study locations
NCT04829175: Recruiting study of Pelvic Organ Prolapse and Stress Urinary Incontinence, sponsored by Ethicon.
NCT04829175 is a study of Pelvic Organ Prolapse and Stress Urinary Incontinence that is actively recruiting participants, run by Ethicon. The registered enrollment target is 1,000 participants, above the 120-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (733% higher). The trial reports 10 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04829175, a study of Pelvic Organ Prolapse and Stress Urinary Incontinence, is actively recruiting participants, sponsored by Ethicon.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 10
- Study locations
Study Summary
The objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine prolapse repair (with laparotomic or laparoscopic approach including robotic assisted) using either Gynemesh PS Mesh or Artisyn Mesh in women undergoing surgery for SUI and POP.
Primary Outcome
Objective cure (success) approximately 5-10 years after surgery, defined as a negative standardized cough stress test (CST)
Conditions Studied
Interventions
- DEVICE Intervention
Study Locations (10)
Other
- Krankenhaus der barmherzigen Schwestern - Linz
- Herlev Hospital - Hillerød
- Hopital Jeanne de Flandres - Lille
- Universitatsklinikum Tubingen - Tübingen
- Bio-Medical University Rome - Rome
- Karolinska Institute - Stockholm
Pennsylvania
- University of Pennsylvania - Philadelphia
- UPMC - Pittsburgh
Connecticut
- Yale University - New Haven
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-04-11 |
| Est. Completion | 2038-03-31 |
What NCT04829175 shows while recruiting
NCT04829175 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 120-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (733% higher).
The record links to 2 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 1 intervention - of which Intervention is the first listed.
NCT04829175 lists 10 locations in 4 states (Other, Pennsylvania, Connecticut).
Frequently Asked Questions
What is clinical trial NCT04829175 about?
NCT04829175 is a clinical study titled "Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry". The objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine prolapse repair (with laparotomic or laparoscopic approach including robotic assisted) using either Gynemesh PS Mesh or Artisyn Mesh in women ...
What is the current status of trial NCT04829175?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2022-04-11. Estimated completion is 2038-03-31.
What conditions does trial NCT04829175 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse, Stress Urinary Incontinence.
What interventions are being tested in trial NCT04829175?
The interventions under investigation include: Intervention (DEVICE).
Who is sponsoring clinical trial NCT04829175?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04829175 being conducted?
This trial has 10 study locations across Connecticut, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04829175's enrollment target sits among peer trials
1,000 1st of 40 higher than 40 of 40 other Pelvic Organ Prolapse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Centered Surgery - Preoperative Counseling and Patient Satisfaction
RECRUITING
-
Pessary Experience Study
RECRUITING
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
-
The AccelERate Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI